It works by activating two hormone pathways: GLP-1 (glucagon-like peptide-1) supports appetite regulation and digestion GIP (glucose-dependent insulinotropic polypeptide) helps improve how the body processes sugar and fat Together, these actions reduce hunger, slow digestion, and promote more efficient energy use
doi: 10.1542/peds.2010-2825
In general, a loading dose of twice the daily dose is recommended on the first day of therapy to result in plasma concentrations close to steady-state by the second day of therapy
The MDL includes claims involving Ozempic, Wegovy, Rybelsus, Trulicity, and Mounjaro
Retatrutide side effects appear to be similar to those seen with other GLP-1 medicines such as Wegovy and Mounjaro
Future studies are certainly warranted to extensively characterize the phenotype and neural anatomical projection fields of the GLP-1-/amylin-activated DVC neurons, as well as the role of astrocytes and microglia 67,68 in mediating the enhanced intake and body weight suppressive effects of amylin + GLP-1 combinatorial therapy
